Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.639% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] COc1ccc2c(c1)c(C(=O)CNc1nc(C)cs1)c(C)n2C.I
[b] COc1cccc(NC(=O)CSc2nnc(CN3CCOCC3)n2C)c1
[c] CNC(=O)C(NC(=O)c1ccccc1)=C(C)C
Answer: b. COc1cccc(NC(=O)CSc2nnc(CN3CCOCC3)n2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(NC(=O)CSc2nnc(CN3CCOCC3)n2C)c1
COc1cccc(NC(=O)CSc2nnc(CN3CCOCC3)n2C)c1
N-(3-methoxyphenyl)-2-[[4-methyl-5-(morpholin-4-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide